Reserpine alleviates cisplatin-induced acute kidney injury via anti-ferroptosis and cGAS/STING pathway

Nahua Xu Rong Mu Siyuan Deng Ye Han Yanyun Shi Xuemei Fu Hui Li Qi Yao a Zunyi Medical University,Zunyi,Chinab School of Medicine,Chongqing University,Chongqing,Chinac Department of Obstetrics and Gynecology,Chongqing Health Center for Women and Children (Women and Children's Hospital of Chongqing Medical University),Chongqing,Chinad Medical College of Guizhou University,Guiyang,Chinae Department of Hematology,Southwest Hospital,Third Military Medical University (Army Medical University),Chongqing,China
DOI: https://doi.org/10.1080/0886022x.2024.2406395
IF: 3.222
2024-10-09
Renal Failure
Abstract:Cisplatin plays a pivotal role in the chemotherapy treatment of various cancers, but its use is often limited due to its nephrotoxic side effects. Identifying compounds that can mitigate cisplatin-induced nephrotoxicity is therefore of great importance. This study focused on evaluating the protective effects of reserpine against cisplatin-induced acute kidney injury. Reserpine was found to significantly safeguard against kidney damage caused by cisplatin, as indicated by the decreased levels of serum creatinine, blood urea nitrogen, and lactate dehydrogenase induced by cisplatin. Moreover, reserpine improved kidney histology damage caused by cisplatin treatment, with hematoxylin-eosin and periodic acid-Schiff staining revealing notable recovery from renal injury. Mechanistically, reserpine mitigated oxidative stress triggered by cisplatin and exhibits the ability to inhibit ferroptosis both in vivo and in vitro . Additionally, reserpine blocked the activation of the cGAS/STING signaling pathway and the subsequent expression of inflammatory genes, thus reducing inflammation-driven kidney damage. In summary, the findings suggest that reserpine offers a promising new strategy for preventing nephrotoxicity induced by cisplatin. Schematic diagram showing proposed mechanism on the role of reserpine in protection of cisplatin-induced AKI (Created with bioicons.com). Cisplatin treatment leads to oxidative stress and mitochondrial dysfunction, which releases mitochondrial DNA, activating the cGAS/STING/TBK1/IRF3 signaling cascade and consequently inflammatory cytokine expression. Reserpine could ameliorate cisplatin induced AKI and inflammation by targeting the anti-oxidant pathway and by inhibiting the activation of cGAS/STING signaling.
urology & nephrology
What problem does this paper attempt to address?